Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study Publisher Pubmed



Vitkova M1, 2 ; Diouf I1 ; Malpas C1 ; Horakova D4 ; Kubala Havrdova E4 ; Patti F5, 6 ; Ozakbas S7 ; Izquierdo G8 ; Eichau S8 ; Shaygannejad V9 ; Onofrj M10 ; Lugaresi A11, 12 ; Alroughani R13 ; Prat A14 Show All Authors
Authors
  1. Vitkova M1, 2
  2. Diouf I1
  3. Malpas C1
  4. Horakova D4
  5. Kubala Havrdova E4
  6. Patti F5, 6
  7. Ozakbas S7
  8. Izquierdo G8
  9. Eichau S8
  10. Shaygannejad V9
  11. Onofrj M10
  12. Lugaresi A11, 12
  13. Alroughani R13
  14. Prat A14
  15. Larochelle C14
  16. Girard M14
  17. Duquette P14
  18. Terzi M15
  19. Boz C16
  20. Grandmaison F17
  21. Sola P18
  22. Ferraro D19
  23. Grammond P20
  24. Butzkueven H21, 22
  25. Buzzard K23, 24
  26. Skibina O22, 23, 24
  27. Yamout BI25
  28. Karabudak R26
  29. Gerlach O27
  30. Lechnerscott J28, 29
  31. Maimone D30
  32. Bergamaschi R31
  33. Van Pesch V32, 33
  34. Iuliano G34
  35. Cartechini E35
  36. Jose Sa M36
  37. Ampapa R37
  38. Barnett M38
  39. Hughes SE39
  40. Ramotello CM40
  41. Hodgkinson S41, 42
  42. Spitaleri DLA43
  43. Petersen T44
  44. Butler EG45
  45. Slee M46
  46. Mcguigan C47
  47. Mccombe PA48, 49
  48. Granella F50, 51
  49. Cristiano E52
  50. Prevost J53
  51. Taylor BV54
  52. Sanchezmenoyo JL55
  53. Laureys G56
  54. Van Hijfte L57
  55. Vucic S58
  56. Macdonell RA59
  57. Gray O60
  58. Olascoaga J61
  59. Deri N62
  60. Fragoso YD63
  61. Shaw C64
  62. Kalincik T1, 3

Source: Neurology Published:2022


Abstract

Background and ObjectivesThe severity of multiple sclerosis (MS) varies widely among individuals. Understanding the determinants of this heterogeneity will help clinicians optimize the management of MS. The aim of this study was to investigate the association between latitude of residence, UV B radiation (UVB) exposure, and the severity of MS.MethodsThis observational study used the MSBase registry data. The included patients met the 2005 or 2010 McDonald diagnostic criteria for MS and had a minimum dataset recorded in the registry (date of birth, sex, clinic location, date of MS symptom onset, disease phenotype at baseline and censoring, and ≥1 Expanded Disability Status Scale score recorded). The latitude of each study center and cumulative annualized UVB dose at study center (calculated from National Aeronautics and Space Administration's Total Ozone Mapping Spectrometer) at ages 6 and 18 years and the year of disability assessment were calculated. Disease severity was quantified with Multiple Sclerosis Severity Score (MSSS). Quadratic regression was used to model the associations between latitude, UVB, and MSSS.ResultsThe 46,128 patients who contributed 453,208 visits and a cumulative follow-up of 351,196 patient-years (70% women, mean age 39.2 ± 12 years, resident between latitudes 19°35′ and 56°16′) were included in this study. Latitude showed a nonlinear association with MS severity. In latitudes <40°, more severe disease was associated with higher latitudes (β = 0.08, 95% CI 0.04-0.12). For example, this translates into a mean difference of 1.3 points of MSSS between patients living in Madrid and Copenhagen. No such association was observed in latitudes <40° (β =-0.02, 95% CI-0.06 to 0.03). The overall disability accrual was faster in those with a lower level of estimated UVB exposure before the age of 6 years (β =-0.5, 95% CI-0.6 to 0.4) and 18 years (β =-0.6, 95% CI-0.7 to 0.4), as well as with lower lifetime UVB exposure at the time of disability assessment (β =-1.0, 95% CI-1.1 to 0.9).DiscussionIn temperate zones, MS severity is associated with latitude. This association is mainly, but not exclusively, driven by UVB exposure contributing to both MS susceptibility and severity. © 2022 American Academy of Neurology.
Other Related Docs
12. Comparison of Fingolimod, Dimethyl Fumarate and Teriflunomide for Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2019)